MX6218E - Procedimiento para la preparacion de hidroxi derivados de 2-isopropilamino pirimidina - Google Patents

Procedimiento para la preparacion de hidroxi derivados de 2-isopropilamino pirimidina

Info

Publication number
MX6218E
MX6218E MX808702U MX870280U MX6218E MX 6218 E MX6218 E MX 6218E MX 808702 U MX808702 U MX 808702U MX 870280 U MX870280 U MX 870280U MX 6218 E MX6218 E MX 6218E
Authority
MX
Mexico
Prior art keywords
pirimidine
isopropylamine
procedure
preparation
hydroxy derived
Prior art date
Application number
MX808702U
Other languages
English (en)
Spanish (es)
Inventor
Andre Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX6218(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of MX6218E publication Critical patent/MX6218E/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX808702U 1979-03-10 1980-03-10 Procedimiento para la preparacion de hidroxi derivados de 2-isopropilamino pirimidina MX6218E (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (1)

Publication Number Publication Date
MX6218E true MX6218E (es) 1984-12-21

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
MX808702U MX6218E (es) 1979-03-10 1980-03-10 Procedimiento para la preparacion de hidroxi derivados de 2-isopropilamino pirimidina

Country Status (24)

Country Link
JP (1) JPS55122768A (US20030220297A1-20031127-C00033.png)
AR (1) AR222691A1 (US20030220297A1-20031127-C00033.png)
AU (1) AU533547B2 (US20030220297A1-20031127-C00033.png)
BE (1) BE881752A (US20030220297A1-20031127-C00033.png)
CA (1) CA1132561A (US20030220297A1-20031127-C00033.png)
CH (1) CH644368A5 (US20030220297A1-20031127-C00033.png)
DE (3) DE3050999C2 (US20030220297A1-20031127-C00033.png)
EG (1) EG14282A (US20030220297A1-20031127-C00033.png)
FI (1) FI66357C (US20030220297A1-20031127-C00033.png)
FR (2) FR2451370A1 (US20030220297A1-20031127-C00033.png)
GB (1) GB2045756B (US20030220297A1-20031127-C00033.png)
HK (1) HK55383A (US20030220297A1-20031127-C00033.png)
IE (1) IE49547B1 (US20030220297A1-20031127-C00033.png)
IN (1) IN153791B (US20030220297A1-20031127-C00033.png)
LU (1) LU82185A1 (US20030220297A1-20031127-C00033.png)
MX (1) MX6218E (US20030220297A1-20031127-C00033.png)
MY (1) MY8400200A (US20030220297A1-20031127-C00033.png)
NL (1) NL184833C (US20030220297A1-20031127-C00033.png)
NO (1) NO154054C (US20030220297A1-20031127-C00033.png)
NZ (1) NZ192927A (US20030220297A1-20031127-C00033.png)
OA (1) OA06484A (US20030220297A1-20031127-C00033.png)
PT (1) PT70882A (US20030220297A1-20031127-C00033.png)
SE (1) SE435180B (US20030220297A1-20031127-C00033.png)
SG (1) SG22683G (US20030220297A1-20031127-C00033.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
NZ192927A (en) 1981-07-13
FR2451370B1 (US20030220297A1-20031127-C00033.png) 1983-05-13
NL8001289A (nl) 1980-09-12
FI66357C (fi) 1984-10-10
AU533547B2 (en) 1983-12-01
NO800664L (no) 1980-09-11
DE3016752C2 (US20030220297A1-20031127-C00033.png) 1987-06-25
EG14282A (en) 1983-09-30
NO154054B (no) 1986-04-01
IE49547B1 (en) 1985-10-30
CH644368A5 (en) 1984-07-31
AU5624880A (en) 1980-09-18
DE3009071C2 (de) 1985-11-14
NL184833B (nl) 1989-06-16
CA1132561A (en) 1982-09-28
GB2045756A (en) 1980-11-05
NL184468B (nl) 1989-03-01
NL184833C (nl) 1989-11-16
HK55383A (en) 1983-11-25
NO154054C (no) 1986-07-09
LU82185A1 (fr) 1980-06-06
AR222691A1 (es) 1981-06-15
OA06484A (fr) 1981-07-31
JPS55122768A (en) 1980-09-20
GB2045756B (en) 1983-01-26
DE3016752A1 (de) 1980-12-04
IN153791B (US20030220297A1-20031127-C00033.png) 1984-08-18
FR2451191A1 (fr) 1980-10-10
FI66357B (fi) 1984-06-29
DE3050999A1 (US20030220297A1-20031127-C00033.png) 1985-08-14
SE8001812L (sv) 1980-09-11
MY8400200A (en) 1984-12-31
FR2451191B1 (US20030220297A1-20031127-C00033.png) 1983-04-29
BE881752A (fr) 1980-05-30
IE800477L (en) 1980-09-10
SE435180B (sv) 1984-09-10
FR2451370A1 (fr) 1980-10-10
JPS6126996B2 (US20030220297A1-20031127-C00033.png) 1986-06-23
FI800566A (fi) 1980-09-11
SG22683G (en) 1983-12-16
PT70882A (en) 1980-03-01
DE3050999C2 (de) 1986-08-14
DE3009071A1 (de) 1980-09-11

Similar Documents

Publication Publication Date Title
ES498228A0 (es) Procedimiento para la preparacion de sulfonilureas
ES491913A0 (es) Procedimiento para la preparacion de betainas
AR227645A1 (es) Procedimiento para la preparacion de oxoalcohilxantinas
MX152233A (es) Procedimiento para la preparacion de polieterpoliaminas
ES493774A0 (es) Procedimiento para la preparacion de 3-amino-sidnoniminas
ES497100A0 (es) Procedimiento para la preparacion de sulfonilureas
MX6218E (es) Procedimiento para la preparacion de hidroxi derivados de 2-isopropilamino pirimidina
ES487746A0 (es) Procedimiento para la preparacion de bis-estiril-benceno
ES493300A0 (es) Procedimiento para la preparacion de acilureas
ES494856A0 (es) Procedimiento para la preparacion de n-aril-n-acil-3-amino- oxazolidin-2-onas
ES491527A0 (es) Procedimiento para la preparacion de tiazoliliden-oxo-pro- pionitrilos
ES490421A0 (es) Procedimiento para la preparacion de diestirilbencenos
ES490420A0 (es) Procedimiento para la preparacion de diestirilbifenilos
ES491139A0 (es) Procedimiento para la preparacion de 2-amino-4-halogeno-5- formil-tiazoleno.
MX151832A (es) Un procedimiento mejorado para la preparacion de un aldehido-eter
AR225159A1 (es) Procedimiento para la preparacion de l-alpha-gliceril-fosforilcolina
MX5878E (es) Procedimiento para la preparacion de hidroxi derivados de isopropilaminopirimidina
MX6151E (es) Procedimiento para la preparacion de 7-acilindolinas
MX6327E (es) Procedimiento para la preparacion de 3-alcoxi-6-alquiliden-hidrazinopiridazina
ES497659A0 (es) Procedimiento para la preparacion de sulfonilureas
ES493001A0 (es) Procedimiento para la preparacion de metilglioxal
AR223383A1 (es) Procedimiento para la preparacion de 2-isopropilamino-pirimidina
ES497099A0 (es) Procedimiento para la preparacion de sulfonilureas
MX6162E (es) Procedimiento para la preparacion de la 2-isopropilamino-pirimidina
ES496862A0 (es) Procedimiento para la preparacion de sulfonil- o sulfinila- cetanilidas fungicidas